Pre-treatment risk predictors of valproic acid-induced dyslipidemia in pediatric patients with epilepsy

Pre-treatment risk predictors of valproic acid-induced dyslipidemia in pediatric patients with epilepsy

Background: Valproic acid (VPA) stands as one of the most frequently prescribed medications in children with newly diagnosed epilepsy. Despite its infrequent adverse effects within therapeutic range, prolonged VPA usage may result in metabolic disturbances including insulin resistance and dyslipidem...

Full description

Bibliographic Details
Main Authors: Tiantian Liang, Chenquan Lin, Hong Ning, Fuli Qin, Bikui Zhang, Yichang Zhao, Ting Cao, Shimeng Jiao, Hui Chen, Yifang He, Hualin Cai
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Pharmacology
Subjects:
valproic acid
dyslipidemia
epilepsy
pediatrics
risk predictors
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1349043/full

Similar Items

Similar Items